News from cytosorbents corporation A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages

Latest

04 Nov, 2019, 07:00 GMT CytoSorbents Enrolls First Patient in TISORB Trial and Opens Operating Subsidiary in the United Kingdom

CytoSorbents Corporation (NASDAQ: CTSO), a leader in blood purification therapies to treat life-threatening conditions, announced the first patient...


11 Jan, 2017, 07:00 GMT Fresenius Medical Care and CytoSorbents Expand Original Partnership and Add New Co-Marketing Agreement for Worldwide CytoSorb® Markets

CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader commercializing its flagship CytoSorb® blood adsorber to treat deadly...


03 Oct, 2016, 12:00 BST International Marketing of CytoSorb® Commences at European Association for Cardio-Thoracic Surgery Conference

CytoSorbents Corporation (NASDAQ: CTSO), manufacturer of the CytoSorb® extracorporeal cytokine adsorber that targets the reduction of excessive...


01 Jun, 2016, 12:00 BST CytoSorbents Announces Fresenius Medical Care Initiates Sales of CytoSorb® in France, Poland and Scandinavia

CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader commercializing its flagship CytoSorb® blood purification cartridge to...


17 Mar, 2016, 09:28 GMT Cytosorb Study: PAMPs and DAMPs Removed

3rd Cytosorb Usermeeting with excellent results The 3rd International CytoSorb Users Meeting held one day in advance of the ISICEM, one of the...


26 Feb, 2016, 09:10 GMT Data Presented on First CytoSorb® Investigator-Initiated Septic Shock Study

Encouraging top line results fuel hopes for potentially life-saving treatment CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy...


19 May, 2015, 14:04 BST CytoSorbents and Alphamedix Team To Introduce CytoSorb® to Israel

CytoSorbents Corporation (NASDAQ: CTSO), a leader in critical care immunotherapy commercializing its CytoSorb® extracorporeal cytokine adsorber to...


16 Dec, 2014, 08:27 GMT CytoSorbents Announces Strategic Partnership with Fresenius Medical Care

CytoSorbents Corporation (OTCQB: CTSOD), a leader in critical care immunotherapy and blood purification, announced yesterday that they have entered...